Form 4 for ELV Elevance Health
Accepted 2022-03-14 00:00:00 ET · period of report 2022-03-10 · accession 0001156039-22-000040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-14 | 2022-03-10 | ELV | Haytaian Peter D | EVP, Pres, DBG, IngenioRx | S - Sale+OE | $460.71 | -17.7K | 23.4K | -43% | -$8.16M |
| D | 2022-03-14 | 2022-03-10 | ELV | Haytaian Peter D | EVP, Pres, DBG, IngenioRx | M - OptEx | $131.80 | +1,848 | 29.9K | +7% | +$243.6K |
| D | 2022-03-14 | 2022-03-10 | ELV | Haytaian Peter D | EVP, Pres, DBG, IngenioRx | M - OptEx | $0.00 | -1,848 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-10 | S | D | 40 | $463.40 | 12,161 | D | — | — | |
| 2 | Common | Common Stock | 2022-03-10 | S | D | 1,240 | $462.73 | 12,201 | D | — | — | (F6) This transaction was executed in multiple trades at prices ranging from $462.34 to $463.25. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2022-03-10 | S | D | 5,874 | $461.72 | 13,441 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $461.27 to $462.26. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2022-03-10 | M | A | 1,848 | $131.80 | 29,864 | D | — | — | |
| 5 | Common | Common Stock | 2022-03-10 | S | D | 4,105 | $460.68 | 19,315 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $460.26 to $461.19. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 6 | Common | Common Stock | 2022-03-10 | S | D | 2,170 | $458.68 | 27,694 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $458.18 to $459.13. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 7 | Common | Common Stock | 2022-03-10 | S | D | 4,274 | $459.75 | 23,420 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $459.25 to $460.24. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 8 | Derivative | Employee Stock Option (Right to Buy) | 2022-03-10 | M | D | 1,848 | $0.00 | 0 | D | $131.80 · — to 2026-03-01 | 1,848 Common Stock | (F7) The option represents a right to purchase a total of 24,348 shares and is exercisable in six semi-annual installments, with six installments of 4,058 shares each beginning on September 1, 2016, which is the six-month anniversary of the date on which the option was granted. |